[Vardenafil for the treatment of erectile dysfunction in men with diabetes].

  • Xiaoxiong Wang
  • Published 2004 in
    Zhonghua nan ke xue = National journal of…

Abstract

The prevalence of erectile dysfunction (ED) is higher in diabete patients than in non-diabete men. Moreover, the treatment of ED is more challenging in men with diabetes. Vardenafil, a novel and highly selective phosphodiesterase 5 inhibitor, is the first line therapy for the broad ED population. Recent large-scale clinical trials indicated that vardenafil improved erectile function in ED men with diabetes regardless of the baseline ED severity and plasma HbA1c levels, and it was generally well tolerated.

Cite this paper

@article{Wang2004VardenafilFT, title={[Vardenafil for the treatment of erectile dysfunction in men with diabetes].}, author={Xiaoxiong Wang}, journal={Zhonghua nan ke xue = National journal of andrology}, year={2004}, volume={10 10}, pages={794-7} }